Cargando…
Metformin Protects against Diabetic Cardiomyopathy: An Association between Desmin–Sarcomere Injury and the iNOS/mTOR/TIMP-1 Fibrosis Axis
The intermediate filament protein desmin is essential for maintaining the structural integrity of sarcomeres, the fundamental unit of cardiac muscle. Diabetes mellitus (DM) can cause desmin to become dysregulated, following episodes of nitrosative stress, through the activation of the iNOS/mTOR/TIMP...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139128/ https://www.ncbi.nlm.nih.gov/pubmed/35625721 http://dx.doi.org/10.3390/biomedicines10050984 |
_version_ | 1784714786466955264 |
---|---|
author | Dawood, Amal F. Alzamil, Norah M. Hewett, Peter W. Momenah, Maha A. Dallak, Mohammad Kamar, Samaa S. Abdel Kader, Dina H. Yassin, Hanaa Haidara, Mohamed A. Maarouf, Amro Al-Ani, Bahjat |
author_facet | Dawood, Amal F. Alzamil, Norah M. Hewett, Peter W. Momenah, Maha A. Dallak, Mohammad Kamar, Samaa S. Abdel Kader, Dina H. Yassin, Hanaa Haidara, Mohamed A. Maarouf, Amro Al-Ani, Bahjat |
author_sort | Dawood, Amal F. |
collection | PubMed |
description | The intermediate filament protein desmin is essential for maintaining the structural integrity of sarcomeres, the fundamental unit of cardiac muscle. Diabetes mellitus (DM) can cause desmin to become dysregulated, following episodes of nitrosative stress, through the activation of the iNOS/mTOR/TIMP-1 pathway, thereby stimulating collagen deposition in the myocardium. In this study, type 2 diabetes mellitus (T2DM) was induced in rats. One group of animals was pre-treated with metformin (200 mg/kg) prior to diabetes induction and subsequently kept on metformin until sacrifice at week 12. Cardiac injuries developed in the diabetic rats as demonstrated by a significant (p < 0.0001) inhibition of desmin immunostaining, profound sarcomere ultrastructural alterations, substantial damage to the left ventricular tissue, collagen deposition, and abnormal ECG recordings. DM also significantly induced the cardiac expression of inducible nitric oxide synthase (iNOS), mammalian target of rapamycin (mTOR), and the profibrogenic biomarker tissue inhibitor of metalloproteinase-1 (TIMP-1). The expression of all these markers was significantly inhibited by metformin. In addition, a significant (p < 0.0001) correlation between desmin tissue levels/sarcomere damage and glycated hemoglobin, heart rate, iNOS, mTOR, and fibrosis was observed. These findings demonstrate an association between damage of the cardiac contractile unit—desmin and sarcomere—and the iNOS/mTOR/TIMP-1/collagen axis of fibrosis in T2DM-induced cardiomyopathy, with metformin exhibiting beneficial cardiovascular pleiotropic effects. |
format | Online Article Text |
id | pubmed-9139128 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91391282022-05-28 Metformin Protects against Diabetic Cardiomyopathy: An Association between Desmin–Sarcomere Injury and the iNOS/mTOR/TIMP-1 Fibrosis Axis Dawood, Amal F. Alzamil, Norah M. Hewett, Peter W. Momenah, Maha A. Dallak, Mohammad Kamar, Samaa S. Abdel Kader, Dina H. Yassin, Hanaa Haidara, Mohamed A. Maarouf, Amro Al-Ani, Bahjat Biomedicines Article The intermediate filament protein desmin is essential for maintaining the structural integrity of sarcomeres, the fundamental unit of cardiac muscle. Diabetes mellitus (DM) can cause desmin to become dysregulated, following episodes of nitrosative stress, through the activation of the iNOS/mTOR/TIMP-1 pathway, thereby stimulating collagen deposition in the myocardium. In this study, type 2 diabetes mellitus (T2DM) was induced in rats. One group of animals was pre-treated with metformin (200 mg/kg) prior to diabetes induction and subsequently kept on metformin until sacrifice at week 12. Cardiac injuries developed in the diabetic rats as demonstrated by a significant (p < 0.0001) inhibition of desmin immunostaining, profound sarcomere ultrastructural alterations, substantial damage to the left ventricular tissue, collagen deposition, and abnormal ECG recordings. DM also significantly induced the cardiac expression of inducible nitric oxide synthase (iNOS), mammalian target of rapamycin (mTOR), and the profibrogenic biomarker tissue inhibitor of metalloproteinase-1 (TIMP-1). The expression of all these markers was significantly inhibited by metformin. In addition, a significant (p < 0.0001) correlation between desmin tissue levels/sarcomere damage and glycated hemoglobin, heart rate, iNOS, mTOR, and fibrosis was observed. These findings demonstrate an association between damage of the cardiac contractile unit—desmin and sarcomere—and the iNOS/mTOR/TIMP-1/collagen axis of fibrosis in T2DM-induced cardiomyopathy, with metformin exhibiting beneficial cardiovascular pleiotropic effects. MDPI 2022-04-23 /pmc/articles/PMC9139128/ /pubmed/35625721 http://dx.doi.org/10.3390/biomedicines10050984 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Dawood, Amal F. Alzamil, Norah M. Hewett, Peter W. Momenah, Maha A. Dallak, Mohammad Kamar, Samaa S. Abdel Kader, Dina H. Yassin, Hanaa Haidara, Mohamed A. Maarouf, Amro Al-Ani, Bahjat Metformin Protects against Diabetic Cardiomyopathy: An Association between Desmin–Sarcomere Injury and the iNOS/mTOR/TIMP-1 Fibrosis Axis |
title | Metformin Protects against Diabetic Cardiomyopathy: An Association between Desmin–Sarcomere Injury and the iNOS/mTOR/TIMP-1 Fibrosis Axis |
title_full | Metformin Protects against Diabetic Cardiomyopathy: An Association between Desmin–Sarcomere Injury and the iNOS/mTOR/TIMP-1 Fibrosis Axis |
title_fullStr | Metformin Protects against Diabetic Cardiomyopathy: An Association between Desmin–Sarcomere Injury and the iNOS/mTOR/TIMP-1 Fibrosis Axis |
title_full_unstemmed | Metformin Protects against Diabetic Cardiomyopathy: An Association between Desmin–Sarcomere Injury and the iNOS/mTOR/TIMP-1 Fibrosis Axis |
title_short | Metformin Protects against Diabetic Cardiomyopathy: An Association between Desmin–Sarcomere Injury and the iNOS/mTOR/TIMP-1 Fibrosis Axis |
title_sort | metformin protects against diabetic cardiomyopathy: an association between desmin–sarcomere injury and the inos/mtor/timp-1 fibrosis axis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139128/ https://www.ncbi.nlm.nih.gov/pubmed/35625721 http://dx.doi.org/10.3390/biomedicines10050984 |
work_keys_str_mv | AT dawoodamalf metforminprotectsagainstdiabeticcardiomyopathyanassociationbetweendesminsarcomereinjuryandtheinosmtortimp1fibrosisaxis AT alzamilnorahm metforminprotectsagainstdiabeticcardiomyopathyanassociationbetweendesminsarcomereinjuryandtheinosmtortimp1fibrosisaxis AT hewettpeterw metforminprotectsagainstdiabeticcardiomyopathyanassociationbetweendesminsarcomereinjuryandtheinosmtortimp1fibrosisaxis AT momenahmahaa metforminprotectsagainstdiabeticcardiomyopathyanassociationbetweendesminsarcomereinjuryandtheinosmtortimp1fibrosisaxis AT dallakmohammad metforminprotectsagainstdiabeticcardiomyopathyanassociationbetweendesminsarcomereinjuryandtheinosmtortimp1fibrosisaxis AT kamarsamaas metforminprotectsagainstdiabeticcardiomyopathyanassociationbetweendesminsarcomereinjuryandtheinosmtortimp1fibrosisaxis AT abdelkaderdinah metforminprotectsagainstdiabeticcardiomyopathyanassociationbetweendesminsarcomereinjuryandtheinosmtortimp1fibrosisaxis AT yassinhanaa metforminprotectsagainstdiabeticcardiomyopathyanassociationbetweendesminsarcomereinjuryandtheinosmtortimp1fibrosisaxis AT haidaramohameda metforminprotectsagainstdiabeticcardiomyopathyanassociationbetweendesminsarcomereinjuryandtheinosmtortimp1fibrosisaxis AT maaroufamro metforminprotectsagainstdiabeticcardiomyopathyanassociationbetweendesminsarcomereinjuryandtheinosmtortimp1fibrosisaxis AT alanibahjat metforminprotectsagainstdiabeticcardiomyopathyanassociationbetweendesminsarcomereinjuryandtheinosmtortimp1fibrosisaxis |